Posted in | News | Nanoenergy

Breakthrough Demonstrates Ability to Manufacture Flexible CIGS Modules With Greater Than 10% Efficiency

Ascent Solar Technologies, Inc. (NASDAQ:ASTI), a developer of state-of-the-art flexible thin-film solar modules, today announced that it has achieved its initial target module efficiency goal of 10.0% for its flexible Copper, Indium, Gallium, Selenide (CIGS) monolithically integrated modules.

The U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) has independently verified that the modules measured as high as 10.4% in conversion efficiency. The modules tested at NREL were standard 429 cm2 modules produced by the company’s 1.5MW production line that was put into commercial production in the first quarter of 2009.

Dr. Prem Nath, Sr. Vice President of Production Operations for Ascent Solar, stated, “This is a significant breakthrough in demonstrating our ability to manufacture monolithically integrated flexible CIGS modules with greater than 10% module efficiency in commercial production. Ascent’s high-volume 30MW commercial plant is scheduled to commence initial production at the beginning of 2010. Module efficiency of 10.0% is a vital element for our low-cost-per-watt manufacturing goal in high volume and will establish Ascent Solar as a leader in the production of lightweight flexible photovoltaics used for portable power and building integrated photovoltaic (BIPV) products.”

Dr. Harin S. Ullal, Senior Project Manager for the National Center for Photovoltaics at the National Renewable Energy Laboratory, stated, “Ascent Solar has made progress in advancing the state-of-the-art flexible, lightweight thin-film CIGS PV technology. NREL has independently verified module conversion efficiency of more than 10.0% for several thin-film CIGS monolithically integrated modules deposited on flexible, lightweight plastic substrates.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.